OrbiMed Advisors is a prominent investment firm based in New York City, specializing in the healthcare and biotechnology sectors. The firm invests globally across various stages, including Series A, B, C, and beyond, as well as in private equity and venture capital. OrbiMed's investments typically range from early-stage ventures to late-stage companies, focusing on biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Notable portfolio companies include AbCellera Biologics, Adaptive Biotechnologies, and Caris Life Sciences. Key partners include Samuel Isaly, Michael Sheffery, and Arvind Desai. OrbiMed's investment philosophy centers on driving innovation and improving patient outcomes. The firm offers tailored financing solutions and leverages a global team to support portfolio companies. Unique value-add services include strategic guidance and access to a vast network of industry experts.